Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer

CONCLUSIONS: These findings underscore the potential of plasma exosomal biomarkers for early NSCLC diagnosis and metastasis prediction. Notably, CFHR5 stands out as a promising prognostic indicator for NSCLC patients. The clinical utility of exosomal biomarkers offers the potential to enhance the management of NSCLC.PMID:37953280 | DOI:10.1186/s12575-023-00223-0
Source: Biological Procedures Online - Category: Molecular Biology Authors: Source Type: research